AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kellenberger, C. J.
Right arrow Articles by Babyn, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kellenberger, C. J.
Right arrow Articles by Babyn, P. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2004; 183:989-994
© American Roentgen Ray Society


Musculoskeletal Imaging

Radiographic and MRI Features of Deferiprone-Related Arthropathy of the Knees in Patients with ß-Thalassemia

Christian J. Kellenberger1,2, Markus Schmugge3, Traudel Saurenmann3, Lin Di Gennaro3, Stefan W. Eber3, Ulrich V. Willi1 and Paul S. Babyn2

1 Department of Diagnostic Imaging and Radiology, University Children's Hospital, Steinwiesstrasse 75, Zurich CH-8032, Switzerland.
2 Present address: Department of Diagnostic Imaging, The Hospital for Sick Children, 555 University Ave., Toronto, ON M5G 1X8, Canada.
3 Division of Haematology and Immunology, University Children's Hospital, Zurich CH-8032, Switzerland.

OBJECTIVE. This study was undertaken to describe the radiographic and MRI appearances of arthropathy of the knees in 14 patients with ß-thalassemia major undergoing chelation therapy with deferiprone (L1).

MATERIALS AND METHODS. All available radiographs and MRI studies of the knees in 14 ß-thalassemia major patients (mean age, 16.3 years; age range, 7–33 years) undergoing chelation therapy with L1 were retrospectively assessed for changes in the synovium, cartilage, and bone. Imaging findings and signs of knee arthropathy were correlated with chelation therapy and average serum ferritin concentration.

RESULTS. Nine (64%) of the 14 patients developed arthralgia of the knees during treatment with L1. Abnormal imaging findings were present in all symptomatic and two asymptomatic patients (12/14, 86%) and included joint effusion, subchondral bone irregularity, and patellar beaks. Additional MRI findings were thickening and enhancement of the synovium; hypointense bands in the synovium; irregularly thickened epiphyseal and articular cartilage overlying subchondral bone defects; and, on T2-weighted sequences, hyperintense articular cartilage lesions. The degree of knee symptoms at the time of imaging did not reflect the severity of cartilage and subchondral bone changes.

CONCLUSION. Radiologic changes can be seen in L1-related arthropathy and should be recognized. MRI of the knees should be considered in symptomatic children and young adults with thalassemia undergoing L1 chelation therapy for iron overload.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Roentgen Ray Society.